InMed Pharmaceuticals (INM) Goodwill (2021 - 2023)

InMed Pharmaceuticals' Goodwill history runs 3 years deep, the most recent figure standing at $868761.0 for Q2 2023.

• On a quarterly basis, Goodwill fell 24.04% year-over-year to $868761.0 in Q2 2023; TTM through Jun 2023 was $868761.0, a 24.04% decrease from a year earlier, with the FY2023 full-year figure at $868761.0, down 24.04% from the prior year.
• Goodwill retreated to $868761.0 in Q2 2023 per INM's latest filing, from $1.1 million in the prior quarter.
• Across five years, Goodwill topped out at $2.0 million in Q4 2021 and bottomed at $868761.0 in Q2 2023.
• The 3-year median for Goodwill is $1.7 million (2021), against an average of $1.6 million.
• Across the five-year window, Goodwill sank 34.14% in 2022 and retreated 24.04% in 2023, its largest moves.
• Year by year, Goodwill stood at $2.0 million in 2021, then slumped by 43.47% to $1.1 million in 2022, then dropped by 24.04% to $868761.0 in 2023.
• Per Business Quant, the three latest INM Goodwill figures stand at $868761.0 (Q2 2023), $1.1 million (Q2 2022), and $2.0 million (Q1 2022).